GlaxoSmithKline (GSK) has released an update.
GlaxoSmithKline (GSK) has reported a transaction involving the sale of 3,551 ordinary shares by Sally Jackson, Senior Vice President of Global Communications & CEO Office. The shares were sold at a price of £16.8719 each on the London Stock Exchange on March 25, 2024. This financial move is detailed in the company’s latest filing with the SEC and reflects the ongoing market activities of GSK’s executives.
For further insights into GSK stock, check out TipRanks’ Stock Analysis page.